Synthetic Biologics (AMEX: SYN)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Synthetic Biologics (AMEX: SYN) through any online brokerage.
There are no as such competitors for Synthetic Biologics.
The latest price target for Synthetic Biologics (AMEX: SYN) was reported by Maxim Group on Friday, March 12, 2021. The analyst firm set a price target for 0.00 expecting SYN to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Synthetic Biologics (AMEX: SYN) is $0.2035 last updated June 28, 2022, 7:59 PM UTC.
There are no upcoming dividends for Synthetic Biologics.
Synthetic Biologics’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Synthetic Biologics.
Synthetic Biologics is in the Healthcare sector and Biotechnology industry. They are listed on the AMEX.